Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 83 of 83 publications.

Umscheid CA, Maguire MG, Pines JM, Everett WW, Baren JM, Townsend RR, Mines D, Szyld D, Gross R. Untreated hypertension and the emergency department: a chance to intervene? Acad Emerg Med. 2008 Jun;15(6):529-36. doi: 10.1111/j.1553-2712.2008.00132.x

Demopoulos L, Polinsky M, Steele G, Mines D, Blum M, Caulfield M, Adamkovic A, Liu Q, Harler MB, Hahn C, Singh A. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials. Transplant Proc. 2008 Jun;40(5):1407-10. doi: 10.1016/j.transproceed.2008.03.084

Herrinton LJ, Liu L, Shoor S, Mines D. Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996-2002. Ann Rheum Dis. 2008 Apr;67(4):574-5. doi: 10.1136/ard.2007.075986

Mines D, Gu Y, Liu Q, Horne LN, Harrison MJ. Risk of active tuberculosis (TB) among biologic-naïve RA patients: retrospective cohort study in a US claims database. Presented at the 2008 Annual European Congress of Rheumatology; June 2008. Paris, France. [abstract] Ann Rheum Dis. 2008; 67(Supplement II):91.

Bongartz T, Warren FC, Mines D, Matteson EL, Abrams KR, Sutton AJ. Etanercept therapy in rheumatoid arthritis and the risk of malignancies. Presented at the 2008 Annual European Congress of Rheumatology; June 2008. Paris, France. [abstract] Ann Rheum Dis. 2008; 67(Supplement II):51.

Mines D, Fireman B, Lee J, Go AS. Venlafaxine use was not associated with an increased risk of sudden cardiac death. Presented at the 23rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2007. Quebec City, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2007 Aug; 16(Suppl 2):S7.

Mines D, Novelli L. Letter to the editor. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis. 2007 Feb 15;44(4):619-20.

Rubino A, Roskell NS, Tennis P, Mines D, Weich S, Andrews E. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ. 2007 Feb 3;334(7587):242-5.

Mines D, Gu Y, Novelli L, Lui Q, Gelfand J. Risk of CNS demyelinating diseases among patients with psoriasis and rheumatoid arthritis. Poster presented at the 2007 59th Annual Meeting of the American Academy of Neurology; May 2007. Boston, MA. [abstract] Neurology. 2007; 68(12, Suppl 1):A165.

Umscheid CA, Maguire MG, Pines JM, Everett WW, Baren JM, Townsend RR, Mines D, Szyld D, Gross R. The prevalence of and risk factors associated with untreated hypertension in ED patients. Poster presented at the 2007 Society for Academic Emergency Medicine Conference; May 2007. Chicago, IL. [abstract] Acad Emerg Med. 2007; 14(5 Suppl 1):S117.

Fireman B, Mines D, Lee J, Hunkeler EM. The risk of suicide in patients treated with venlafaxine, fluoxetine, citalopram, or paroxetine at Kaiser Permanente in Northern California. Poster presented at the 2006 Summer Meeting of the British Association for Psychopharmacology; July 2006. Oxford, United Kingdom. [abstract] J Psychopharmacol. 2006 Sep; 20(5 Suppl):A58.

Mines D. Attributing treatment as a cause in individuals and populations. Presented at the 2006 Annual European Congress of Rheumatology; June 22, 2006. Amsterdam, The Netherlands. [abstract] Ann Rheum Dis. 2006; 65(Suppl 2):15.

Rubino A, Roskell NS, Tennis P, Mines D, Weich S, Andrews E. Risk of suicide during venlafaxine and comparator antidepressants treatment. Presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006; 15:S40-1.

Mines DI, Novelli LA, Yu H. Lymphoma risk in patients with rheumatoid arthritis who received 2 or more disease modifying anti-rheumatic drugs (DMARDs): a retrospective cohort study in the GPRD. Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Aug; 14(S2):S30.

Mines D, Hill D, Yu H, Novelli L. Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram. Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):367-72.

Mines D, Novelli L. The risk of first seizure associated with mefenamic acid in women of reproductive age. Poster presented at the 2004 20th International Conference on Pharmacoepidemiology; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(S1).

Mines DI, Novelli L. The risk of upper gastrointestinal tract bleeding associated with mefenamic acid in women of reproductive age. Poster presented at the 2004 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):S54-5. doi: 10.1002/pds.987

Mines DI, Yu H, Hill DD. Fracture risk is increased in patients with ankylosing spondylitis: a population-based study in the General Practice Research Database. Presented at the 2004 Annual European Congress of Rheumatology (EULAR); June 11, 2004. Berlin, Germany.

Liu Z, Eaton SC, McQuay LJ, Mines D, Irish WD, Wang L. Protective value of influenza vaccination for other household members of vaccinated children. Poster presented at the 2003 41st Annual Meeting of the Infectious Disease Society of America; October 2003. San Diego, CA.

Mines DI, Wang L, Guo D, Xue S. The incidence of Myasthenia Gravis (MG) in the General Practice Research Database (GPRD): a validation study. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th International Conference on Pharmacoepidemiology; August 22, 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1).

Mines D, Fosnocht KM, Berlin JA, Strom BL. Can primary care physicians diagnose innocent heart murmurs? Presented at the 1999 22nd Annual Meeting of the Society for General Internal Medicine; May 1, 1999. San Francisco, CA. [abstract] J Gen Intern Med. 1999 Feb; 14(Suppl 2):113. doi: 10.1046/j.1525-1497.1999.1420005.x

Mines D, Rosenzweig S. Letter to the editor. Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke. JAMA. 1999 Jan 6;281(1):31.

Stahmer SA, Raps EC, Mines DI. Carotid and vertebral artery dissections. Emerg Med Clin North Am. 1997 Aug;15(3):677-98.

Mines D, Stahmer S, Shepherd SM. Poisonings: food, fish, shellfish. Emerg Med Clin North Am. 1997 Feb;15(1):157-77.

Mines D, Abbuhl SB. Hydroxyapatite pseudopodagra in a young man: acute calcific periarthritis of the first metatarsophalangeal joint. Am J Emerg Med. 1996 Mar;14(2):180-2.

Mines D, Rosenzweig S. Pain Management. In: Harwood-Nuss A, Linden C, Luten RC, Shepherd S, Wolfson A, editors. The clinical practice of emergency medicine. 2nd ed. Philadelphia: PA. JB Lippincott; 1996. p.1575-81.

Mines D. Letter to the editor. Of worms and red herrings. Lancet. 1995 Nov 25;346(8987):1438.

Mines D. The ED status board as a threat to patient confidentiality. Ann Emerg Med. 1995 Jun;25(6):855-6.

Tanus T, Mines D, Atkins PC, Levinson AI. Serum tryptase in idiopathic anaphylaxis: a case report and review of the literature. Ann Emerg Med. 1994 Jul;24(1):104-7.

Mines D. Gabrielle takes off. J Emerg Med. 1994 Jan;12(1):103-6.

Mines D, Abbuhl S. Needle thoracostomy fails to detect a fatal tension pneumothorax. Ann Emerg Med. 1993 May;22(5):863-6.

Mines D. Splenic artery aneurysm rupture. Am J Emerg Med. 1991 Jan;9(1):74-6.

Mines DI. Surgery looms. J Gen Intern Med. 1990 Jul;5:318. doi: 10.1007/BF02600399